Weight Watchers will announce Q4 and 2025 results on March 16, 2026, followed by a conference call.
Quiver AI Summary
Weight Watchers (WW International, Inc.) announced that it will release its fourth quarter and full year 2025 financial results on March 16, 2026, before the market opens, followed by a conference call at 8:30 a.m. ET to discuss the findings. The call will be available through a live webcast on the company's website, with a replay offered for 90 days. WW emphasizes its position as a leader in science-backed weight management, combining medical expertise, technology, and community support to tailor solutions for its members. The company highlights its commitment to personalized care and access to clinical interventions, including GLP-1 medications, to support healthier living. Forward-looking statements in the release caution investors about potential risks and uncertainties, urging them to consult SEC filings for more information.
Potential Positives
- Weight Watchers is set to release its financial results for Q4 and full year 2025, indicating transparency and ongoing engagement with investors.
- The company will host a conference call with leadership to discuss results, providing stakeholders with direct access to management insights.
- Weight Watchers emphasizes its position as a global leader in weight management, backed by over 60 years of scientific research, enhancing its credibility in the market.
- The release highlights the integration of cutting-edge technology and personalized support, reinforcing Weight Watchers’ commitment to innovative solutions in weight management.
Potential Negatives
- The press release does not provide any specific financial metrics or performance indicators ahead of the earnings report, which may raise concerns among investors about potential underperformance or lack of transparency.
- The reliance on forward-looking statements highlights uncertainty and risk, potentially diminishing investor confidence in the company's future performance and strategies.
- The statement about "contradictory advice" in the weight management industry may implicitly position the company as defensive, suggesting they perceive significant competition and skepticism about their offerings.
FAQ
When will Weight Watchers release its 2025 results?
Weight Watchers will release its results for the fourth quarter and full year 2025 on March 16, 2026.
What time is the Weight Watchers conference call?
The conference call to discuss the results will take place at 8:30 a.m. ET on March 16, 2026.
Where can I access the Weight Watchers webcast?
The webcast will be available on Weight Watchers' corporate website under Events and Presentations.
What support does Weight Watchers offer for weight management?
Weight Watchers provides a science-backed support system, combining expertise, technology, community, and personalized interventions.
How can I contact Weight Watchers for investor inquiries?
For investor inquiries, you can contact John Mills or Anna Kate Heller at [email protected].
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$WW Insider Trading Activity
$WW insiders have traded $WW stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $WW stock by insiders over the last 6 months:
- CARNEY HAWKS has made 2 purchases buying 29,057 shares for an estimated $643,464 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$WW Revenue
$WW had revenues of $172.1M in Q3 2025. This is a decrease of -10.78% from the same period in the prior year.
You can track WW financials on Quiver Quantitative's WW stock page.
$WW Hedge Fund Activity
We have seen 50 institutional investors add shares of $WW stock to their portfolio, and 44 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- COOPER CREEK PARTNERS MANAGEMENT LLC added 528,042 shares (+433.0%) to their portfolio in Q4 2025, for an estimated $15,426,747
- PLUSTICK MANAGEMENT LLC removed 210,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $6,135,150
- JPMORGAN CHASE & CO removed 185,279 shares (-48.6%) from their portfolio in Q4 2025, for an estimated $5,412,925
- INVESCO SENIOR SECURED MANAGEMENT INC /ADV added 170,751 shares (+inf%) to their portfolio in Q4 2025, for an estimated $4,988,490
- WESTERN ASSET MANAGEMENT COMPANY, LLC added 143,989 shares (+inf%) to their portfolio in Q3 2025, for an estimated $3,939,539
- FRANKLIN RESOURCES INC added 135,949 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,971,750
- AEGON USA INVESTMENT MANAGEMENT, LLC removed 111,568 shares (-38.0%) from their portfolio in Q4 2025, for an estimated $3,259,459
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”) will release its results for the fourth quarter and full year 2025 ended December 31, 2025 before market open on Monday, March 16, 2026.
Weight Watchers will host a conference call to discuss results at 8:30 a.m. ET the same day. The webcast of the conference call will be available on the Company’s corporate website, corporate.ww.com , under Events and Presentations. A replay of the webcast will be available on this site for at least 90 days.
About Weight Watchers
Weight Watchers is the global leader in science-backed weight management, offering an integrated support system built for the GLP-1 era that combines scientific expertise, medication, cutting-edge technology, and human connection. With more than 60 years of experience, Weight Watchers is the most studied commercial weight management program in the world, delivered through its No. 1 U.S. doctor-recommended weight-loss program. Its holistic, personalized approach also includes U.S.-based clinical interventions and access to GLP-1 medications when clinically appropriate, and a global network of coaches and community support. Since 1963, the company has led with science to deliver its members the personalized support they need to reach and sustain their goals. Members can access these solutions directly, or through Weight Watchers for Business’ full-spectrum platform for employers, health plans, and payers. In a landscape crowded with contradictory advice, isolating apps, and one-size-fits-all solutions, Weight Watchers offers a proven path forward that is rooted in research, grounded in empathy and designed to help every member feel better in their body and live a longer, healthier life. For more information, visit weightwatchers.com.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by the Company pursuant to United States securities laws contain discussions of these risks and uncertainties. The Company assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are advised to review the Company's filings with the United States Securities and Exchange Commission (which are available on the SEC's EDGAR database at www.sec.gov and via the Company's website at corporate.ww.com).
For investor inquiries, please contact:
John Mills or Anna Kate Heller
[email protected]
For media inquiries, please contact:
Lizzy Levitan
[email protected]
